Home Search

viaskin - search results

If you're not happy with the results, please do another search

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the AAAAI Conference

5
We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

0
The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.
Viaskin Peanut

Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years

After three years of treatment, more than 70% could tolerate about three to four peanut kernels.
Research Lab

A new era in food allergy treatment has begun

0
Innovative treatments aim to do more than manage symptoms; they offer the potential for long-term remission and even a cure.
Newletter Archive

Newsletter Archive

0
Catch up on past newsletters.
Viaskin Peanut

Children’s Response to Peanut Patch Therapy Increased Over 60 Months

0
VP250 may lead to an accumulation of clinical benefit with high treatment compliance, making this a valuable option for children with allergies.
Viaskin Patch

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study

68.2% of subjects completed the oral food challenge (~12-14 peanut kernels) without meeting stopping criteria, compared to 30.7% at month 12.
Viaskin-Patch

FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial to Commence

0
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
Viaskin Patch

Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut Allergy

0
According to research presented at this year's #ACAAI22 meeting.
Viaskin Peanut

Private Law Firm to Investigate Claims on Behalf of Investors in DBV Technologies

0
It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.